Neurisol (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry into nerve terminals, decreasing the release of excitatory neurotransmitters like glutamate and substance P, thereby reducing neuronal hyper‑excitability and pain transmission.

The appropriate dose of Neurisol is determined individually by a qualified prescriber based on the patient’s medical condition, age, renal function and response to therapy. Healthcare professionals will establish the dosing regimen and any necessary adjustments.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Neurisol. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with many traditional anticonvulsants, gabapentin has a distinct mechanism targeting calcium channel subunits rather than sodium channels. It is generally well tolerated, has fewer drug‑enzyme interactions, and is often chosen for patients who need adjunct seizure control or neuropathic pain relief, though efficacy varies by individual condition.

Neurisol should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Neurisol is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets (or capsules) should be swallowed whole with a glass of water. Patients should follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include the potential for severe allergic reactions such as Stevens‑Johnson syndrome, respiratory depression when combined with other CNS depressants, suicidal thoughts or behavior, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, difficulty breathing, mood changes or unexplained bruising.

Neurisol is contraindicated in patients with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled depression, or a history of suicidal ideation. Pregnant or breastfeeding women should only use it after thorough risk‑benefit evaluation by their healthcare provider.